生命科学资讯

Scribe Therapeutics plans to test cholesterol-lowering therapy this summer

Manufacturers benefit as pharma customers invest back in US

Jazz sells priority review voucher for $200M, scoring highest price in a decade

Health tech funding rounds get bigger when Andreessen Horowitz and General Catalyst join

#JPM26: Drugmakers want US reforms, not to slow down China

ImmunityBio's Anktiva lung cancer data; Glaukos' glaucoma implant sales disappoint

Thermo Fisher to lay off 421 workers as it winds down lab product site in North Carolina

Caldera Therapeutics erupts with $112.5M and a China-originated IBD bispecific

#JPM26: Day 3 at the JP Morgan Healthcare Conference

#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlook

FDA delays decision on expanding label for Travere's kidney disorder drug

FDA requests flu vaccine label updates to include febrile seizure risk

FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels

HHS ousts vaccine injury panel members as reshaping takes hold

Trump administration appears to have ended its US trade probe into pharma

VantAI gets $80M and new name; Dynavax discloses it had pre-Sanofi suitor

AbbVie reaches MFN deal with the White House, pledges billions to US manufacturing

Marea takes drug for acromegaly to Phase 2

Novartis licenses radiopharma asset from Chinese biotech for $50M upfront

#JPM26: Day 2 at the JP Morgan Healthcare Conference